Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial

Brigid M. Lynch, Nga H. Nguyen, Melissa M. Moore, Marina M. Reeves, Dori E. Rosenberg, Terry Boyle, Shakira Milton, Christine M. Friedenreich, Jeff K. Vallance, Dallas R. English

Research output: Contribution to journalArticle

Abstract

Background: This brief report examines the maintenance of moderate to vigorous physical activity (MVPA) and sedentary behavior changes approximately 12 weeks after the delivery of the ACTIVATE Trial primary intervention (use of the Garmin Vivofit 2 activity tracker coupled with a behavioral feedback and goal-setting session and 5 telephone-delivered health coaching sessions). We also examine the efficacy of an abridged intervention (use of the Garmin Vivofit 2 only) in the waitlist control group. Methods: A pre-post design was employed to examine the secondary aims of the ACTIVATE Trial (n = 80; mean age = 62 years). MVPA and sedentary behavior were measured using Actigraph and activPAL accelerometers after delivery of the primary intervention (T2), and again 12 weeks later (T3). Linear mixed models with random effects were used to examine within-group changes in MVPA and sitting time variables. Results: After the 12-week follow-up period, women in the primary intervention group had maintained their higher levels of MVPA (change from T2 to T3 = 14 min/wk; 95% CI = −18 to 46; P =.37). However, their sitting time increased slightly, by 7 min/d (95% CI = −20 to 34; P =.58), but it did not return to its preintervention level. After receiving the Garmin Vivofit 2, the waitlist control group increased their MVPA by 33 min/wk (95% CI = 3-64; P =.03) and reduced their sitting time by 38 min/d (95% CI = −69 to −7; P =.02) over the same 12-week period. Conclusion: The secondary outcomes from the ACTIVATE Trial suggest that wearable technology may generate sustainable changes in MVPA and sitting time. Wearable technology alone may be sufficient to change behavior, at least in the short term.

LanguageEnglish
Pages2856-2860
Number of pages5
JournalCancer
Volume125
Issue number16
DOIs
Publication statusPublished - 15 Aug 2019

Keywords

  • accelerometry
  • breast neoplasms
  • exercise
  • fitness trackers
  • sedentary lifestyle
  • survivors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lynch, Brigid M. ; Nguyen, Nga H. ; Moore, Melissa M. ; Reeves, Marina M. ; Rosenberg, Dori E. ; Boyle, Terry ; Milton, Shakira ; Friedenreich, Christine M. ; Vallance, Jeff K. ; English, Dallas R. / Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention : Secondary outcomes from the ACTIVATE Trial. In: Cancer. 2019 ; Vol. 125, No. 16. pp. 2856-2860.
@article{8d8efb0d6a034e4397c7c03024db24ae,
title = "Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial",
abstract = "Background: This brief report examines the maintenance of moderate to vigorous physical activity (MVPA) and sedentary behavior changes approximately 12 weeks after the delivery of the ACTIVATE Trial primary intervention (use of the Garmin Vivofit 2 activity tracker coupled with a behavioral feedback and goal-setting session and 5 telephone-delivered health coaching sessions). We also examine the efficacy of an abridged intervention (use of the Garmin Vivofit 2 only) in the waitlist control group. Methods: A pre-post design was employed to examine the secondary aims of the ACTIVATE Trial (n = 80; mean age = 62 years). MVPA and sedentary behavior were measured using Actigraph and activPAL accelerometers after delivery of the primary intervention (T2), and again 12 weeks later (T3). Linear mixed models with random effects were used to examine within-group changes in MVPA and sitting time variables. Results: After the 12-week follow-up period, women in the primary intervention group had maintained their higher levels of MVPA (change from T2 to T3 = 14 min/wk; 95{\%} CI = −18 to 46; P =.37). However, their sitting time increased slightly, by 7 min/d (95{\%} CI = −20 to 34; P =.58), but it did not return to its preintervention level. After receiving the Garmin Vivofit 2, the waitlist control group increased their MVPA by 33 min/wk (95{\%} CI = 3-64; P =.03) and reduced their sitting time by 38 min/d (95{\%} CI = −69 to −7; P =.02) over the same 12-week period. Conclusion: The secondary outcomes from the ACTIVATE Trial suggest that wearable technology may generate sustainable changes in MVPA and sitting time. Wearable technology alone may be sufficient to change behavior, at least in the short term.",
keywords = "accelerometry, breast neoplasms, exercise, fitness trackers, sedentary lifestyle, survivors",
author = "Lynch, {Brigid M.} and Nguyen, {Nga H.} and Moore, {Melissa M.} and Reeves, {Marina M.} and Rosenberg, {Dori E.} and Terry Boyle and Shakira Milton and Friedenreich, {Christine M.} and Vallance, {Jeff K.} and English, {Dallas R.}",
year = "2019",
month = "8",
day = "15",
doi = "10.1002/cncr.32142",
language = "English",
volume = "125",
pages = "2856--2860",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "16",

}

Lynch, BM, Nguyen, NH, Moore, MM, Reeves, MM, Rosenberg, DE, Boyle, T, Milton, S, Friedenreich, CM, Vallance, JK & English, DR 2019, 'Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial', Cancer, vol. 125, no. 16, pp. 2856-2860. https://doi.org/10.1002/cncr.32142

Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention : Secondary outcomes from the ACTIVATE Trial. / Lynch, Brigid M.; Nguyen, Nga H.; Moore, Melissa M.; Reeves, Marina M.; Rosenberg, Dori E.; Boyle, Terry; Milton, Shakira; Friedenreich, Christine M.; Vallance, Jeff K.; English, Dallas R.

In: Cancer, Vol. 125, No. 16, 15.08.2019, p. 2856-2860.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention

T2 - Cancer

AU - Lynch, Brigid M.

AU - Nguyen, Nga H.

AU - Moore, Melissa M.

AU - Reeves, Marina M.

AU - Rosenberg, Dori E.

AU - Boyle, Terry

AU - Milton, Shakira

AU - Friedenreich, Christine M.

AU - Vallance, Jeff K.

AU - English, Dallas R.

PY - 2019/8/15

Y1 - 2019/8/15

N2 - Background: This brief report examines the maintenance of moderate to vigorous physical activity (MVPA) and sedentary behavior changes approximately 12 weeks after the delivery of the ACTIVATE Trial primary intervention (use of the Garmin Vivofit 2 activity tracker coupled with a behavioral feedback and goal-setting session and 5 telephone-delivered health coaching sessions). We also examine the efficacy of an abridged intervention (use of the Garmin Vivofit 2 only) in the waitlist control group. Methods: A pre-post design was employed to examine the secondary aims of the ACTIVATE Trial (n = 80; mean age = 62 years). MVPA and sedentary behavior were measured using Actigraph and activPAL accelerometers after delivery of the primary intervention (T2), and again 12 weeks later (T3). Linear mixed models with random effects were used to examine within-group changes in MVPA and sitting time variables. Results: After the 12-week follow-up period, women in the primary intervention group had maintained their higher levels of MVPA (change from T2 to T3 = 14 min/wk; 95% CI = −18 to 46; P =.37). However, their sitting time increased slightly, by 7 min/d (95% CI = −20 to 34; P =.58), but it did not return to its preintervention level. After receiving the Garmin Vivofit 2, the waitlist control group increased their MVPA by 33 min/wk (95% CI = 3-64; P =.03) and reduced their sitting time by 38 min/d (95% CI = −69 to −7; P =.02) over the same 12-week period. Conclusion: The secondary outcomes from the ACTIVATE Trial suggest that wearable technology may generate sustainable changes in MVPA and sitting time. Wearable technology alone may be sufficient to change behavior, at least in the short term.

AB - Background: This brief report examines the maintenance of moderate to vigorous physical activity (MVPA) and sedentary behavior changes approximately 12 weeks after the delivery of the ACTIVATE Trial primary intervention (use of the Garmin Vivofit 2 activity tracker coupled with a behavioral feedback and goal-setting session and 5 telephone-delivered health coaching sessions). We also examine the efficacy of an abridged intervention (use of the Garmin Vivofit 2 only) in the waitlist control group. Methods: A pre-post design was employed to examine the secondary aims of the ACTIVATE Trial (n = 80; mean age = 62 years). MVPA and sedentary behavior were measured using Actigraph and activPAL accelerometers after delivery of the primary intervention (T2), and again 12 weeks later (T3). Linear mixed models with random effects were used to examine within-group changes in MVPA and sitting time variables. Results: After the 12-week follow-up period, women in the primary intervention group had maintained their higher levels of MVPA (change from T2 to T3 = 14 min/wk; 95% CI = −18 to 46; P =.37). However, their sitting time increased slightly, by 7 min/d (95% CI = −20 to 34; P =.58), but it did not return to its preintervention level. After receiving the Garmin Vivofit 2, the waitlist control group increased their MVPA by 33 min/wk (95% CI = 3-64; P =.03) and reduced their sitting time by 38 min/d (95% CI = −69 to −7; P =.02) over the same 12-week period. Conclusion: The secondary outcomes from the ACTIVATE Trial suggest that wearable technology may generate sustainable changes in MVPA and sitting time. Wearable technology alone may be sufficient to change behavior, at least in the short term.

KW - accelerometry

KW - breast neoplasms

KW - exercise

KW - fitness trackers

KW - sedentary lifestyle

KW - survivors

UR - http://www.scopus.com/inward/record.url?scp=85064663455&partnerID=8YFLogxK

U2 - 10.1002/cncr.32142

DO - 10.1002/cncr.32142

M3 - Article

VL - 125

SP - 2856

EP - 2860

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 16

ER -